DRUG
TARGET · FEATURE
USE
NOTES
Nonselective muscarinic antagonist, tertiary
Symptomatic bradycardia, organophosphate poisoning, ↓ secretions
Endpoint in poisoning: drying of bronchial secretions, not pupil size
Quaternary — no CNS
Preoperative ↓ secretions, with neostigmine, drooling
No delirium
Tertiary, strong CNS action
Motion sickness (transdermal patch)
Sedation, confusion in elderly
Inhaled, quaternary; M3 blockade in airways
COPD (tiotropium long-acting), acute asthma add-on
Dry mouth; little systemic effect
Oxybutynin · tolterodine · solifenacin · darifenacin
M3 antagonists at detrusor
Urge incontinence, overactive bladder
Dry mouth, constipation, cognitive effects (oxybutynin worst)
Benztropine · trihexyphenidyl
Central muscarinic antagonists
Parkinson tremor, acute dystonia from antipsychotics
Avoid in elderly (confusion)
Tropicamide · cyclopentolate
Topical eye drops
Mydriasis and cycloplegia for exams
Can trigger angle closure
Hyoscyamine · dicyclomine
GI antispasmodics
IBS cramping
Anticholinergic effects
Drugs with hidden anticholinergic effects
First-generation antihistamines, TCAs, low-potency antipsychotics, cyclobenzaprine
—
Cumulative burden → delirium, retention in elderly
Irreversible AChE phosphorylation; lipophilic, absorbed through skin
Parathion, malathion, sarin
Farmworker with pinpoint pupils, wheeze, secretions, fasciculations
Regenerates AChE (cleaves phosphate) — must be given before "aging"
Organophosphate poisoning (with atropine)
Reverses nicotinic (muscle) and muscarinic effects; acts peripherally
Reversible AChE inhibitors
Similar picture, shorter
Pralidoxime less needed